CARsgen Therapeutics Holdings Ltd. had a revenue of 73.45M in the quarter ending Dec 31, 2025, with 34.19%. This bring the company's revenue in the last twelve months to 128.19M, Decreased 72.18%. In the fiscal year ending Dec 31, 2025, CARsgen Therapeutics Holdings Ltd. had annual revenue of 122.41M with 210.49% growth.